FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to composition for prevention and treatment of diseases and states, associated with platelet aggregation and platelet-induced thrombosis, including mixture of at least one flavonoid with free B-cycle, of at least one flavane and at least one agent, selected from group, consisting of injection anticoagulant agent, peroral anticoagulant agent, antiplatelet agent, anti-angina medication, non-steroid anti-inflammatory drug (NSAID) or selective cyclooxygenase-2 (COX-2) inhibitor (versions). Method of composition application.
EFFECT: compositions are efficient for prevention and treatment of diseases and states, associated with platelet aggregation and platelet-induced thrombosis.
32 cl, 14 tbl, 11 ex
Authors
Dates
2011-02-20—Published
2006-03-10—Filed